These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 21695985)
1. [The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases]. Krivolapov IuA; Peshkov MV; Leenman EE; Matsionis AE; Kovrigina AM Arkh Patol; 2011; 73(2):25-32. PubMed ID: 21695985 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Benner MF; Jansen PM; Meijer CJ; Willemze R Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236 [TBL] [Abstract][Full Text] [Related]
3. Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study. Torlakovic EE; Naresh K; Kremer M; van der Walt J; Hyjek E; Porwit A J Clin Pathol; 2009 Jun; 62(6):547-51. PubMed ID: 19474355 [TBL] [Abstract][Full Text] [Related]
4. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
5. [The importance of immunohistochemical examination in the diagnosis of malignant lymphoproliferative diseases--the author's personal experience]. Căruntu ID Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):129-33. PubMed ID: 10756784 [TBL] [Abstract][Full Text] [Related]
6. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020 [TBL] [Abstract][Full Text] [Related]
7. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Kikuchi A; Nishikawa T Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520 [TBL] [Abstract][Full Text] [Related]
8. An approach to practical problems in the diagnosis of lymphoproliferative disorders using cytochemistry and immunocytochemistry. Beckstead JH Clin Lab Med; 1988 Mar; 8(1):211-22. PubMed ID: 3282760 [TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoid hyperplasia of the palate: case report and literature review. Jham BC; Binmadi NO; Scheper MA; Zhao XF; Koterwas GE; Kashyap A; Levy BA J Craniomaxillofac Surg; 2009 Mar; 37(2):79-82. PubMed ID: 19138528 [TBL] [Abstract][Full Text] [Related]
10. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894 [TBL] [Abstract][Full Text] [Related]
11. A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry. Warnke R; Pederson M; Williams C; Levy R Am J Clin Pathol; 1978 Dec; 70(6):67-75. PubMed ID: 103428 [TBL] [Abstract][Full Text] [Related]
12. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology. Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796 [TBL] [Abstract][Full Text] [Related]
13. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. Kempf W J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214 [TBL] [Abstract][Full Text] [Related]
14. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201 [TBL] [Abstract][Full Text] [Related]
15. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas. Hallermann C; Niermann C; Fischer RJ; Schulze HJ J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214 [TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders. Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens]. Frank GA; Kaplanskaia IB; Glasko EN; Semenov EA; Roshchina LS; Korolev AV Arkh Patol; 2007; 69(3):15-8. PubMed ID: 17722588 [TBL] [Abstract][Full Text] [Related]
18. An interlaboratory comparison of immunohistochemistry and PCR methods for detection of Neospora caninum in bovine foetal tissues. van Maanen C; Wouda W; Schares G; von Blumröder D; Conraths FJ; Norton R; Williams DJ; Esteban-Redondo I; Innes EA; Mattsson JG; Björkman C; Fernández-García A; Ortega-Mora LM; Müller N; Sager H; Hemphill A Vet Parasitol; 2004 Dec; 126(4):351-64. PubMed ID: 15567040 [TBL] [Abstract][Full Text] [Related]
19. [Histologic diagnosis of lymphoproliferative diseases of the digestive tract]. Ozzello L; Saraga EP; Hurlimann J Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1037-41. PubMed ID: 7423144 [TBL] [Abstract][Full Text] [Related]